Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Soft-Tissue Sarcomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00346164
What this trial is testing

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+26 more
Children's Oncology Group 588
Testing effectiveness (Phase 2)Looking for participantsNCT03624244
What this trial is testing

Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

Who this might be right for
Low Grade Endometrial Stromal Sarcoma
Centre Leon Berard 40
Early research (Phase 1)Looking for participantsNCT04969835
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

Who this might be right for
Salivary Gland TumorUrothelial CarcinomaOvarian Carcinoma+2 more
Avacta Life Sciences Ltd 158
Large-scale testing (Phase 3)Active Not RecruitingNCT01223248
What this trial is testing

Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy

Who this might be right for
MelanomaOvarian CancerSarcoma+4 more
Memorial Sloan Kettering Cancer Center 220
Large-scale testing (Phase 3)Study completedNCT00003212
What this trial is testing

Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 780
Early research (Phase 1)Looking for participantsNCT03715933
What this trial is testing

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Who this might be right for
Ewing SarcomaColorectal Adenocarcinoma
Inhibrx Biosciences, Inc 411
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Testing effectiveness (Phase 2)UnknownNCT01898962
What this trial is testing

Definitive Therapy for Oligometastatic Solid Malignancies

Who this might be right for
Stage IV or Recurrent Carcinoma or Sarcoma
Rocky Mountain Cancer Centers 110
Testing effectiveness (Phase 2)Study completedNCT04095208
What this trial is testing

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

Who this might be right for
Soft Tissue Sarcoma AdultAdvanced Cancer
Institut Bergonié 68
Large-scale testing (Phase 3)Study completedNCT00753688
What this trial is testing

Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy

Who this might be right for
Sarcoma, Soft Tissue
GlaxoSmithKline 369
Testing effectiveness (Phase 2)Study completedNCT02888665
What this trial is testing

Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Sarcoma
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT07193550
What this trial is testing

Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)

Who this might be right for
Bone Sarcomas
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)Study completedNCT02008877
What this trial is testing

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

Who this might be right for
Malignant Peripheral Nerve Sheath Tumors (MPNST)Sarcoma
Sarcoma Alliance for Research through Collaboration 20
Testing effectiveness (Phase 2)Looking for participantsNCT05135975
What this trial is testing

Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Who this might be right for
NeuroblastomaSarcoma
Nationwide Children's Hospital 86
Not applicableEnded earlyNCT03886181
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 2
Early research (Phase 1)Active Not RecruitingNCT06414434
What this trial is testing

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

Who this might be right for
LiposarcomaRecurrent LiposarcomaMetastatic Liposarcoma+4 more
Michael Wagner, MD 24
Not applicableStudy completedNCT04604158
What this trial is testing

Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients

Who this might be right for
CancerCancer MetastaticNeoplasms+20 more
Gillian Gresham 38
Testing effectiveness (Phase 2)Study completedNCT00587964
What this trial is testing

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Who this might be right for
Brain MetastasisBladder CancerBreast Cancer+10 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT00023998
What this trial is testing

Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

Who this might be right for
Metastatic Osteosarcoma
National Cancer Institute (NCI) 80
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Next Page